Subsequently, we divided the HNSCC samples into high-expression and low-expression groups according to the expression level of SEC61G and investigated the correlation between SEC61G expression and the prognosis of patients with different types of cancers, mainly using datasets from the TCGA and GEO databases. This evidence concerns the gene SEC61G and cancer.